Sequana Therapeutics was one of the first genomics companies and it was founded by Avalon. Although Avalon had intensely studied the area for a half decade prior, the Firm waited to see seminal developments in the field of positional cloning which would enable the relatively rapid isolation and characterization of disease genes, yielding novel targets for bio-pharmaceutical discovery.